Testing effectiveness (Phase 2)Ended earlyNCT04203160
What this trial is testing
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
Who this might be right for
Biliary Tract Cancer
University of Michigan Rogel Cancer Center 75